-
The clinical data of 9 domestic liver disease centers confirmed that rutromopag is safe and effectiv...
Rutrombopag provides more treatment options for CLD patients in China.
2022-11-18 11:43 -
Aβ monoclonal antibody is broken again, Alzheimer's disease new drug research and development is a ...
Roche defeated one after another, what is the next move?
2022-11-18 11:43 -
Ascletis announces that the clinical trial application for ASC10 monkeypox indication has been appro...
ASC10 is an oral double prodrug.
2022-11-18 11:43 -
The world's first! RSV prevention therapy for infants and young children was approved, and the tens ...
Which therapies are worth looking forward to?
2022-11-17 13:57 -
The first in the world! Huadong Pharmaceutical's new FRα target ADC was approved by the FDA
Huadong Medicine said that ELAHERE™ is the world's first FRα-target ADC drug.
2022-11-17 13:54 -
Out of money? Another Biotech sold the plant at a loss and announced its entry into the CRO
If you lose money, you have to sell, what happened to Hebo Pharmaceutical?
2022-11-17 13:50 -
Roche Phase III failure is out? Biogen/Eisai and Eli Lilly seize the AD opportunity
This is not Roche's first failure in the AD field this year.
2022-11-17 13:45 -
Behind the prequalification of Sinovac's varicella vaccine, the 'SV-1 cell line' is indispensable
Sinovac live attenuated varicella vaccine passed WHO prequalification.
2022-11-17 11:23 -
The world's first! Infant RSV prevention therapy approved, tens of billions of market ushered in com...
The development of any drug/vaccine carries significant risks, and RSV is no exception.
2022-11-17 10:38 -
8 billion, the 'secret' layout outside the vaccine disc, and the distribution of dual antibody, CGT,...
The love of the market, will disappear, and line and cherish.
2022-11-17 10:38
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- BASF Launches Second Round of ... Jul 24, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
Related Products